![Synthesis of Mitomycin C and Decarbamoylmitomycin C N(2) deoxyguanosine-adducts. - Abstract - Europe PMC Synthesis of Mitomycin C and Decarbamoylmitomycin C N(2) deoxyguanosine-adducts. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4807628/bin/nihms761391u1.jpg)
Synthesis of Mitomycin C and Decarbamoylmitomycin C N(2) deoxyguanosine-adducts. - Abstract - Europe PMC
![Differential Activation of p53 by the Various Adducts of Mitomycin C* - Journal of Biological Chemistry Differential Activation of p53 by the Various Adducts of Mitomycin C* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9883dce5-5b8d-4aa1-917b-165ee9a22008/grfc1.jpg)
Differential Activation of p53 by the Various Adducts of Mitomycin C* - Journal of Biological Chemistry
![Frontiers | Mitomycin C Inhibits Esophageal Fibrosis by Regulating Cell Apoptosis and Autophagy via lncRNA-ATB and miR-200b | Molecular Biosciences Frontiers | Mitomycin C Inhibits Esophageal Fibrosis by Regulating Cell Apoptosis and Autophagy via lncRNA-ATB and miR-200b | Molecular Biosciences](https://www.frontiersin.org/files/Articles/675757/fmolb-08-675757-HTML/image_m/fmolb-08-675757-g006.jpg)
Frontiers | Mitomycin C Inhibits Esophageal Fibrosis by Regulating Cell Apoptosis and Autophagy via lncRNA-ATB and miR-200b | Molecular Biosciences
![Frontiers | Chemo-Radiotherapy of Oligometastases of Colorectal Cancer With Pegylated Liposomal Mitomycin-C Prodrug (Promitil): Mechanistic Basis and Preliminary Clinical Experience | Oncology Frontiers | Chemo-Radiotherapy of Oligometastases of Colorectal Cancer With Pegylated Liposomal Mitomycin-C Prodrug (Promitil): Mechanistic Basis and Preliminary Clinical Experience | Oncology](https://www.frontiersin.org/files/Articles/423301/fonc-08-00544-HTML/image_m/fonc-08-00544-g004.jpg)
Frontiers | Chemo-Radiotherapy of Oligometastases of Colorectal Cancer With Pegylated Liposomal Mitomycin-C Prodrug (Promitil): Mechanistic Basis and Preliminary Clinical Experience | Oncology
![Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil®): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues | Semantic Scholar Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil®): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/926d85e7ec8b7c213348e29e531338ae34134454/5-Figure1-1.png)
Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil®): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues | Semantic Scholar
A New Mechanism of Action for the Anticancer Drug Mitomycin C: Mechanism-Based Inhibition of Thioredoxin Reductase | Chemical Research in Toxicology
![Frontiers | Lack of the Bacterial Phytochrome Protein Decreases Deinococcus radiodurans Resistance to Mitomycin C | Microbiology Frontiers | Lack of the Bacterial Phytochrome Protein Decreases Deinococcus radiodurans Resistance to Mitomycin C | Microbiology](https://www.frontiersin.org/files/MyHome%20Article%20Library/659233/659233_Thumb_400.jpg)
Frontiers | Lack of the Bacterial Phytochrome Protein Decreases Deinococcus radiodurans Resistance to Mitomycin C | Microbiology
![Cells | Free Full-Text | The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines Cells | Free Full-Text | The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines](https://www.mdpi.com/cells/cells-09-01775/article_deploy/html/images/cells-09-01775-ag.png)